Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Danaher Corporation

Danaher Corporation (DHR-PB) Stock Overview

Explore Danaher Corporation’s financial performance, market position, analyst ratings, and future outlook.

DHR-PB●NYSE
HealthcareMedical - Diagnostics & Research
$1261.26
$9.94(0.78%)
U.S. Market opens in 13h 57m

Danaher Corporation (DHR-PB)

Meyka AI Score

Z

Key Financials

Market Cap916.8B
P/E Ratio35.08
EPS (TTM)$8.64
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$1900.80

DHR-PB Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Danaher Corporation (NYSE: DHR-PB) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Danaher Corporation's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of DHR-PB on the NYSE shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $1900.80 for the NYSE listing.

Key metrics behind Danaher Corporation's NYSE-traded stock include a P/E ratio of 35.08 and a market capitalization of 916.8B. Combined with our AI analysis, these give both institutional and retail investors a clear view of DHR-PB on the NYSE.

Price Performance (NYSE: DHR-PB)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-0.00%
3-Month Change
-3.51%
6-Month Change
-7.27%
Year-to-Date (YTD) Change
-6.08%
1-Year Change
1.12%
3-Year Change
41.16%
5-Year Change
40.18%
All-Time (Max) Change
40.18%

Contact Information

https://www.danaher.com
202 828 0850
2200 Pennsylvania Avenue, NW, Washington, DC, 20037-1701

Company Facts

790,000 Employees
IPO DateMay 11, 2020
CountryUS

Frequently Asked Questions